113
Participants
Start Date
February 29, 2016
Primary Completion Date
March 31, 2019
Study Completion Date
January 31, 2020
CLBS03 Low Dose
CLBS03 High Dose
Placebo
University of Florida, Gainesville
University of Miami, Diabetes Research Institute, Miami
Vanderbilt Eskind Diabetes Clinic, Nashville
Indiana University, Indianapolis
University of Minnesota, Minneapolis
Sanford Research, Sioux Falls
Sanford Research, Fargo
Children's Mercy Kansas City, Kansas City
Baylor College of Medicine / Texas Children's Hospital, Houston
Barbara Davis Center for Diabetes, Aurora
Rady Children's Hospital, San Diego
University of California, San Francisco, San Francisco
Oregon Health Science University, Portland
Yale University School of Medicine, New Haven
Joslin Diabetes Center, Boston
Lead Sponsor
Sanford Health
OTHER
California Institute for Regenerative Medicine (CIRM)
OTHER
Lisata Therapeutics, Inc.
INDUSTRY